Free Trial

TRxADE HEALTH (MEDS) Competitors

TRxADE HEALTH logo
$1.45 -0.01 (-0.68%)
As of 07/3/2025

MEDS vs. UGRO, CTNT, JXJT, WTER, CUEN, BIMI, AENTW, CHSCP, CHSCO, and CHSCN

Should you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include urban-gro (UGRO), Cheetah Net Supply Chain Service (CTNT), JX Luxventure (JXJT), Alkaline Water (WTER), Cuentas (CUEN), BIMI (BIMI), Alliance Entertainment (AENTW), CHS (CHSCP), CHS (CHSCO), and CHS (CHSCN). These companies are all part of the "wholesale" industry.

TRxADE HEALTH vs. Its Competitors

TRxADE HEALTH (NASDAQ:MEDS) and urban-gro (NASDAQ:UGRO) are both small-cap wholesale companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TRxADE HEALTH
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
urban-gro
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

TRxADE HEALTH has higher earnings, but lower revenue than urban-gro.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TRxADE HEALTH$7.45M0.27-$17.84MN/AN/A
urban-gro$71.54M0.06-$25.44M-$1.12-0.28

urban-gro has a net margin of 0.00% compared to TRxADE HEALTH's net margin of -149.81%. urban-gro's return on equity of 0.00% beat TRxADE HEALTH's return on equity.

Company Net Margins Return on Equity Return on Assets
TRxADE HEALTH-149.81% -196.79% -112.21%
urban-gro N/A N/A N/A

TRxADE HEALTH has a beta of 2.32, indicating that its share price is 132% more volatile than the S&P 500. Comparatively, urban-gro has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500.

5.7% of TRxADE HEALTH shares are owned by institutional investors. Comparatively, 20.6% of urban-gro shares are owned by institutional investors. 48.4% of TRxADE HEALTH shares are owned by insiders. Comparatively, 26.9% of urban-gro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, TRxADE HEALTH and TRxADE HEALTH both had 1 articles in the media. TRxADE HEALTH's average media sentiment score of 0.00 equaled urban-gro'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TRxADE HEALTH
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
urban-gro
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

urban-gro beats TRxADE HEALTH on 7 of the 11 factors compared between the two stocks.

Get TRxADE HEALTH News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEDS vs. The Competition

MetricTRxADE HEALTHDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$2.04M$2.79M$5.53B$9.05B
Dividend YieldN/AN/A5.24%4.03%
P/E RatioN/AN/A19.7920.15
Price / Sales0.270.27421.02118.60
Price / CashN/AN/A36.8958.07
Price / Book3.223.228.045.67
Net Income-$17.84M-$17.84M$3.18B$249.13M
7 Day Performance48.29%16.10%2.82%3.30%
1 Month Performance72.00%24.00%3.70%5.20%
1 Year Performance-91.78%-30.59%35.41%21.38%

TRxADE HEALTH Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDS
TRxADE HEALTH
N/A$1.45
-0.7%
N/A-91.7%$2.04M$7.45M0.0050News Coverage
UGRO
urban-gro
0.3959 of 5 stars
$0.32
-7.9%
N/A-77.2%$4.35M$71.54M-0.28100News Coverage
Gap Up
CTNT
Cheetah Net Supply Chain Service
N/A$1.20
-4.8%
N/A-82.9%$3.37M$460K-0.5918Gap Down
JXJT
JX Luxventure
N/A$2.42
-1.2%
N/A+6.7%$1.47M$38.49M0.0057
WTER
Alkaline Water
0.6156 of 5 stars
$0.02
-8.7%
N/AN/A$430K$62.39M-0.5040
CUEN
Cuentas
0.062 of 5 stars
$0.00
+18.2%
N/A-100.0%$4K$1.79M-0.015Gap Up
BIMI
BIMI
N/A$0.00
flat
N/AN/A$1K$12.63M0.00520
AENTW
Alliance Entertainment
N/A$0.15
-9.4%
N/A+291.7%$0.00$1.07B0.00847Positive News
CHSCP
CHS
N/A$27.71
+0.3%
N/A-10.3%$0.00$39.26B0.0010,730Upcoming Earnings
CHSCO
CHS
N/A$26.30
-0.2%
N/A-3.9%$0.00$32.64B0.0010,000Upcoming Earnings
CHSCN
CHS
N/A$24.67
+0.5%
N/A-3.8%$0.00$32.64B0.0010,000Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:MEDS) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners